GB SCIENCES INC Quarterly Debt-to-equity in % from Q2 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Gb Sciences Inc quarterly Debt-to-equity history and growth rate from Q2 2016 to Q3 2024.
  • Gb Sciences Inc Debt-to-equity for the quarter ending September 30, 2024 was -102 %, a 4.13% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -102 +4.4 +4.13% Sep 30, 2024
Q2 2024 -103 +24.8 +19.4% Jun 30, 2024
Q1 2024 -104 +47 +31.2% Mar 31, 2024
Q4 2023 -105 +82.4 +43.9% Dec 31, 2023
Q3 2023 -106 +436 +80.4% Sep 30, 2023
Q2 2023 -128 +434 +77.3% Jun 30, 2023
Q1 2023 -151 +600 +79.9% Mar 31, 2023
Q4 2022 -188 +805 +81.1% Dec 31, 2022
Q3 2022 -543 +41.2 +7.05% Sep 30, 2022
Q2 2022 -561 +85.5 +13.2% Jun 30, 2022
Q1 2022 -750 -27 -3.73% Mar 31, 2022
Q4 2021 -993 -84 -9.25% Dec 31, 2021
Q3 2021 -584 -2K -141% Sep 30, 2021
Q2 2021 -647 -927 -330% Jun 30, 2021
Q1 2021 -723 -874 -581% Mar 31, 2021
Q4 2020 -909 -1.01K -1001% Dec 31, 2020
Q3 2020 1.42K +1.32K +1391% Sep 30, 2020
Q2 2020 281 +196 +231% Jun 30, 2020
Q1 2020 151 +74.5 +97.9% Mar 31, 2020
Q4 2019 101 +27 +36.5% Dec 31, 2019
Q3 2019 95 +25.2 +36.2% Sep 30, 2019
Q2 2019 84.7 +8.23 +10.8% Jun 30, 2019
Q1 2019 76.1 -2.26 -2.89% Mar 31, 2019
Q4 2018 73.9 -3.37 -4.36% Dec 31, 2018
Q3 2018 69.7 -12.5 -15.2% Sep 30, 2018
Q2 2018 76.4 -25.7 -25.2% Jun 30, 2018
Q1 2018 78.4 -82.8 -51.4% Mar 31, 2018
Q4 2017 77.2 -602 -88.6% Dec 31, 2017
Q3 2017 82.2 +1.24K Sep 30, 2017
Q2 2017 102 +451 Jun 30, 2017
Q1 2017 161 Mar 31, 2017
Q4 2016 679 Dec 31, 2016
Q3 2016 -1.16K Sep 30, 2016
Q2 2016 -349 Jun 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.